About Us Strategy & Mission Our Values Our People Our Board Our Collaborations Contact Our Programmes Overview Pipeline C. difficile Infection Enterobacteriaceae ESKAPE Programme Clinical Trials Stewardship Compassionate Use Our Science Discuva Platform Publications Investors Investor Centre Press Releases Financial Reports & Filings Email Alerts Events & Presentations Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
In Vitro Pharmacodynamics Of The Novel Antibiotic SMT19969 Against Clostridium Difficile In Vitro Pharmacodynamics Of The Novel Antibiotic SMT19969 Against Clostridium Difficile April 12, 2014 By CKD Digital
In Vitro Pharmacodynamics Of The Novel Antibiotic SMT19969 Against Clostridium Difficile April 12, 2014 By CKD Digital
